Aster Sanad Hospital Supports Saudi Talent at PSCEMS Career Day
These initiatives reflect the group's mission to achieve excellence and sustainability across all aspects of healthcare service delivery in the Kingdom.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Bawaba
3 days ago
- Al Bawaba
Aster Sanad Hospital Supports Saudi Talent at PSCEMS Career Day
Aster Sanad Hospital, one of the leading healthcare institutions under the Aster DM Healthcare Group, proudly participated as an official sponsor at the Career Expo Day hosted by Prince Sultan bin Abdulaziz College for Emergency Medical Services (PSCEMS). The participation reflects the hospital's ongoing commitment to supporting Saudization efforts, attracting promising local talent, and investing in the future of the Kingdom's healthcare sector, in line with Saudi Vision 2030 platform for young professionalsThe event brought together a promising generation of graduates in the field of emergency medical services, and served as a dynamic platform for interaction, knowledge exchange, and exploring professional Sanad Hospital's participation aimed not only to scout emerging talent but also to support national efforts toward the development of local healthcare and talent scoutingDuring the event, the Aster Sanad team actively engaged with a large number of graduates and received a significant number of resumes from ambitious young professionals aspiring to begin their careers in the healthcare sector. The hospital team also provided an overview of its workplace culture, professional development programs, training opportunities, and future career the next generation'We were truly inspired by the level of knowledge, motivation, and professionalism we witnessed among the students,' said Falah Al-Sharari, Head of Human Resources at Aster DM Hospitals & Clinics – KSA. 'These future healthcare professionals reflect the great potential of Saudi talent, and we look forward to welcoming some of them into our team as we continue to grow and strengthen our presence in the Kingdom.'Mr. Al-Sharari also expressed his appreciation to Prince Sultan College for organizing such a valuable event, underscoring the importance of strengthening collaboration between academic institutions and healthcare providers across the Kingdom. Such partnerships play a key role in preparing a new generation of qualified professionals capable of meeting the evolving needs of the workplace cultureAster Sanad's participation is in line with the group's commitment to building a supportive and inclusive work environment grounded in trust, appreciation, mutual respect, and open dialogue. This culture encourages employees to contribute to internal policy development and enhances engagement and satisfaction within the to Vision 2030As part of Aster DM Healthcare's expanding footprint across the GCC, Aster Sanad remains dedicated to contributing to Saudi Arabia's Vision 2030 by offering world-class medical services, creating high-quality employment opportunities, and strengthening healthcare infrastructure. These initiatives reflect the group's mission to achieve excellence and sustainability across all aspects of healthcare service delivery in the Kingdom.
Al Bawaba
4 days ago
- Al Bawaba
Director of Indonesian Hospital in Gaza killed in Israeli airstrike
Published July 2nd, 2025 - 11:51 GMT ALBAWABA - The director of the Indonesian Hospital, Dr. Marwan Al-Sultan, was killed in an Israeli airstrike in the Gaza Strip. According to Quds News Network, Dr. Marwan Al-Sultan was killed in an airstrike that hit near the 17 Junction west of Gaza City on Wednesday. BREAKING: Dr. Marwan Al-Sultan, director of the Indonesian Hospital, was killed in an Israeli airstrike near the 17 Junction west of Gaza City. — Quds News Network (@QudsNen) July 2, 2025 © 2000 - 2025 Al Bawaba (
Al Bawaba
25-06-2025
- Al Bawaba
WCM-Q research highlights Qatar's path to ‘global health excellence' in cancer care and research
Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have conducted a comprehensive study of Qatar's pioneering national cancer care and research strategy, highlighting the country's significant achievements in improving prevention, detection and treatment of the disease. The report, published in the leading UK medical journal Lancet Oncology, notes the remarkable success of Qatar's investments in advanced clinical and research infrastructure, cutting-edge technologies, and recruitment of highly skilled healthcare professionals over the past two decades, which have transformed the country into a regional leader in cancer care. Areas of particular strength in Qatar's system of cancer care - which has been shaped by the National Cancer Strategy (2010) and the Qatar Cancer Plan (2023-26) - include special expertise in precision and personalized medicine, early detection (based on well-developed screening facilities and schedules), and robustly evidence-based cancer management following diagnosis, leading to improved survival rates. The research, titled 'Qatar national cancer care and research: pioneering strategies for global health excellence,' also highlights areas where some challenges still exist, including late-stage diagnosis, low health literacy relating to cancer among some demographic groups in Qatar, and data collection and long-term analysis. WCM-Q's Dr. Lotfi Chouchane, professor of genetic medicine and professor of microbiology and immunology, is the senior author of the paper. The report, and a subsequent paper also published in Lancet Oncology, additionally highlights the potential for establishing beneficial regional and global collaborations on cancer care and research, particularly with Saudi Arabia and Jordan. This subsequent paper, titled 'Bridging borders for resilience in cancer control in the Middle East: a strategic alliance of Saudia Arabia, Qatar, and Jordan' also provides an epidemiological breakdown of patterns of cancer burden in the three countries. Dr. Murugan Subramanian, senior research associate, is a co-first author of the paper, with Dr. Chouchane serving as a co-senior author. Other researchers who contributed include Sheikh Dr. Mohammed Bin Hamad Al-Thani, director of the Public Health Department at the Ministry of Public Health and Associate Professor of Clinical Healthcare Policy and Research at WCM-Q and Qatar University; Dr. Salha Bujassoum, Senior Consultant at the National Centre for Cancer Care and Research; Dr. Khalid Rashid Al-Rumaihi, Head of the Department of Urology at Hamad Medical Corporation; and Dr. Hilal Lashuel, Research Development and Innovation Advisor to the Chairperson of Qatar Foundation and Executive Director of RDI at the Chairperson's Office. Dr. Chouchane said: 'This research shows very clearly that the past two decades have been a huge success story for Qatar in its efforts to establish a truly world-class cancer care and innovation infrastructure. Looking ahead, we identified some challenges to overcome in the areas of community health literacy; cultural sensitivities surrounding important cancer-prevention measures; language barriers; data collection, digitization and long-term analysis; issues around healthcare equity; and the growing global challenge of unhealthy lifestyle choices, which can increase cancer risk. 'We can see, however, that Qatar is already taking steps to address many of these challenges, as is shown by the Qatar Cancer Plan 2023-26, developed by the Ministry of Public Health and the National Cancer Governance Board. One measure we in the healthcare sector advocate is to work closely with like-minded countries in the region - such as Saudi Arabia and Jordan - to share experiences, expertise and datasets, which has the potential to be of huge benefit to the cancer care and research strategies of all participating countries.' The research also draws attention to Qatar's efforts to prioritize the integration of cutting-edge precision and personalized medicine protocols into clinical practice - a measure which is already having a significant positive impact on survival rates. Indeed, research by Dr. Chouchane's lab at WCM-Q has been at the forefront of precision medicine approaches to cancer care. He added: 'Precision medicine is one of the most promising areas for cancer research and enhanced patient outcomes, but a limiting factor is that it is dependent on good-quality genomic data matched with good-quality clinical data. Therefore, sharing genomic and clinical data with healthcare systems in neighboring countries who have populations with similar ethnic backgrounds could provide a dramatic boost for precision oncology in the region.'
